Article info

Download PDFPDF

Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Authors

  1. Correspondence to Paula Martinez Sanz; p.martinezsanz{at}sanquin.nl

Citation

Martinez Sanz P, van Rees DJ, Matlung HL, et al
Response to: Correspondence on "G-CSF as a suitable alternative to GM-CSF to boost dinutuximab-mediated neutrophil cytotoxicity in neuroblastoma treatment" by Mora et al

Publication history

  • Accepted October 17, 2021
  • First published December 10, 2021.
Online issue publication 
December 10, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.